We previously developed a technique to isolate subchromatin nucleoprot
ein complexes (NPC) that contain tightly bound genes and enzymatic act
ivities. NPC fractions (NPCF) were prepared by directly treating isola
ted nuclei with MspI to generate six NPCF (S1, M1, S2, M2, 0.1K and R)
. The NPCF have been used to predict the potential efficacy of interfe
ron-alpha (IFN-alpha) treatment in patients with chronic myelogenous l
eukemia (CML) [Nicolson et al., Gene 159 (1995) 105-111]. Here, the NP
CF were probed for the presence of tightly bound c-abl, p53 and bcl-2
genes. We found that the NPCF isolated from the nuclei of leukocytes o
f normal individuals rarely contained detectable quantities of tightly
-bound c-abl, p53 or bcl-2 genes or gene sequences, whereas in CML nuc
lei these genes were often found in tight association with multiple NP
CF. Examination of TPCF isolated from the leukocyte nuclei from patien
ts with highly progressive CML for the presence of the three genes rev
ealed that more NPCF contained the three tightly-bound genes than leuk
ocyte NPCF from patients with stable or less progressed CML. These dat
a suggest that as CML progresses to more malignant states, oncogenes,
suppressor genes and apoptosis-associated genes become tightly associa
ted with NPCF.